Related Experiment Video
Updated: Aug 30, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
The global epidemiology of invasive Candida infections--is the tide turning?
1Mycology Reference Centre, Department of Microbiology, Old Medical School, Leeds General Infirmary, LS1 3EX, Leeds, UK. richard.hobson@leedsth.nhs.uk
Abstract:
Invasive candidiasis is a condition of major medical importance. Its incidence has increased dramatically over the last 50 years, reflecting increasingly interventional standards of medical care. Candida spp. are regularly reported to be the fourth commonest cause of bloodstream infection, and it is perceived that the incidence of invasive Candida spp. infections continues to increase. The global disease burden of invasive Candida spp. infections is difficult to quantify because of wide geographic variation. Data originating from the United States indicate that mortality from candidiasis has been falling since 1989. Data from several locations have shown that the dramatic increases in Candida spp. bloodstream infections seen during the 1980s were not sustained through the 1990s. Some authors have reported a decreasing incidence. The contribution of non-albicans Candida spp. to invasive infection is rising. Invasive infections with Candida spp. continue to represent a major economic burden, increasing both mortality and morbidity in an already expensive group of hospital patients. There remains much scope for ongoing and future research into the epidemiology and basic disease processes underlying these infections.
Insights
Invasive candidiasis, a significant medical issue, has seen rising incidence due to advanced medical care. While mortality rates are falling, the economic burden and the rise of non-albicans Candida species necessitate further research.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Epidemiology
Background:
- Invasive candidiasis represents a major global health concern with increasing incidence over the past 50 years.
- Candida species are a leading cause of hospital-acquired bloodstream infections, posing a significant economic and clinical challenge.
- The rising prevalence of non-albicans Candida species contributes to the complexity of invasive infections.
Purpose of the Study:
- To review the epidemiology and disease burden of invasive candidiasis.
- To analyze trends in incidence, mortality, and the contribution of different Candida species.
- To highlight the economic impact and areas for future research.
Main Methods:
- Literature review of epidemiological data on invasive candidiasis.
- Analysis of trends in bloodstream infection rates and mortality from various geographic locations.
- Examination of the changing species distribution in invasive Candida infections.
Main Results:
- While bloodstream infection rates increased in the 1980s, this trend has not been sustained, with some reports indicating a decrease.
- Mortality from candidiasis has shown a downward trend in the United States since 1989.
- Non-albicans Candida species are increasingly implicated in invasive infections, alongside the persistent economic burden.
Conclusions:
- Invasive candidiasis remains a critical medical issue with a substantial economic burden, despite falling mortality rates in some regions.
- The epidemiology is complex, with geographic variations and a rising proportion of infections caused by non-albicans Candida species.
- Further research into the epidemiology and pathogenesis of these infections is essential.
Related Concept Videos
Candidiasis
Cryptococcal Meningitis
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Infectious Diseases and Their Occurrence
Giardiasis
Antifungal Agents

